{"id":"W2063044382","doi":"10.1053/sonc.2002.37418","title":"Treatment of bone complications in advanced prostate cancer: Rationale for bisphosphonate use and results of a phase III trial with zoledronic acid","year":2002,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Zoledronic acid; Medicine; Prostate cancer; Bisphosphonate; Bone pain; Bone disease; Cancer; Internal medicine; Oncology; Surgery; Urology; Osteoporosis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001468678,0.0002625869,0.002303587,0.0002880826,0.00002802183,0.00000193533,0.00003794725,0.0002258106,0.000006197166],"category_scores_gemma":[0.00009392272,0.0001913686,0.0001115332,0.0003244641,0.0001405425,0.00004176169,0.00001294012,0.0001260308,5.954101e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009800257,"about_ca_system_score_gemma":0.001435972,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000665683,"about_ca_topic_score_gemma":0.002624625,"domain_scores_codex":[0.9978276,0.00008988909,0.001316632,0.0003934793,0.000103628,0.0002687617],"domain_scores_gemma":[0.9979739,0.0006004667,0.0009489506,0.0002765714,0.0001000385,0.0001000995],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.06042506,0.004263631,0.000113699,0.002965045,0.0001480119,0.00006332261,0.000578611,0.000002914307,0.000003682524,0.00002210446,0.00008920203,0.9313247],"study_design_scores_gemma":[0.2828739,0.02023823,0.00005261957,0.007340433,0.0007392397,0.000102954,0.00003412068,0.00003683166,0.00002775403,0.00001351149,0.6884136,0.0001267373],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02701567,0.9613025,0.000002241044,0.0003026013,0.00008130007,0.01009473,0.001115748,0.000007584836,0.00007758404],"genre_scores_gemma":[0.002049585,0.9879075,0.002423798,0.00001918197,0.00001092146,0.005926088,0.0008236707,0.00002756627,0.0008117378],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.931198,"threshold_uncertainty_score":0.7803783,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08148374553096663,"score_gpt":0.4323332133059353,"score_spread":0.3508494677749687,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}